Viewing Study With Definitions



Ignite Creation Date: 2024-05-06 @ 6:40 PM
Last Modification Date: 2024-10-26 @ 2:52 PM
Study NCT ID: NCT05749900
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-03-01
First Post: 2023-02-19

Brief Title: First-line Trastuzumab Gemcitabine Cisplatin and Nivolumab in Advanced HER2- Positive Biliary Tract Cancer a Multicenter Open-label Single-arm Phase IbII Trial HERBOT
Sponsor:
Organization: Yonsei University